CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Option exercise Chief Financial Officer acquired 250,000 shares (option exercise)
- 4 Open-market buy Director bought 20,000 shares at $4.77 ($95,400)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy 10% owner bought 38,000 shares at $3.44 ($130,720)
- 4 Open-market buy 10% owner bought 177,457 shares at $3.27 ($580,284)
- 4 Open-market buy Chief Financial Officer bought 42,600 shares at $3.42 ($145,692)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
Page 2 of 17 · 325 filings